| Title : Resveratrol derived butyrylcholinesterase inhibitors - Csuk_2013_Arch.Pharm.(Weinheim)_346_499 |
| Author(s) : Csuk R , Albert S , Kluge R , Strohl D |
| Ref : Arch Pharm (Weinheim) , 346 :499 , 2013 |
|
Abstract :
Novel polyhydroxylated (E)-stilbenes were synthesized by Mizoroki-Heck reactions and tested for their ability to inhibit the enzymes acetyl- and butyrylcholinesterase. Several of them are good inhibitors of butyrylcholinesterase; one of them carrying an extra fluorine substituent is a 94-fold stronger inhibitor of butyrylcholinesterase than of acetylcholinesterase. |
| PubMedSearch : Csuk_2013_Arch.Pharm.(Weinheim)_346_499 |
| PubMedID: 23722618 |
Csuk R, Albert S, Kluge R, Strohl D (2013)
Resveratrol derived butyrylcholinesterase inhibitors
Arch Pharm (Weinheim)
346 :499
Csuk R, Albert S, Kluge R, Strohl D (2013)
Arch Pharm (Weinheim)
346 :499